All data are based on the daily closing price as of April 29, 2025
h

Humedix

200670.KQ
26.81 USD
-0.38
-1.40%

Overview

Last close
26.81 usd
Market cap
276.32M usd
52 week high
31.58 usd
52 week low
18.18 usd
Target price
37.63 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
3.5944
Price/Book Value
1.8497
Enterprise Value
212.88M usd
EV/Revenue
1.9073
EV/EBITDA
6.6712

Key financials

Revenue TTM
76.88M usd
Gross Profit TTM
30.52M usd
EBITDA TTM
19.58M usd
Earnings per Share
N/A usd
Dividend
0.46 usd
Total assets
179.00M usd
Net debt
N/A usd

About

Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic, and health functional food products. It is also involved in manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.
  • Symbol
    200670.KQ
  • Exchange
    KQ
  • Isin
    KR7200670008
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Seongnam-si
  • Web site
    https://humedix.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top